List view / Grid view
20 March 2019 | By Iqra Farooq (European Pharmaceutical Review)
A study has revealed an in vitro method that could screen various compounds, identifying ones that would make swallowing medicine easier...
14 March 2019 | By Iqra Farooq
Cablivi and Egaten were the two top novel drugs approved last month, with a focus on parasitic infestation and the rare disorder, aTTP...
6 March 2019 | By European Pharmaceutical Review
Researchers have identified a possible association between use of statins and developing type 2 diabetes after following patients for 15 years...
4 March 2019 | By Iqra Farooq (European Pharmaceutical Review)
The pharmaceutical drug delivery market could reach $1,694.7 billion by 2023, increasing at a CAGR of 6.4 percent during the period...
1 March 2019 | By European Pharmaceutical Review
Oxford Genetics has won six new licensing deals for its scalable drug and gene therapy manufacturing in the synthetic biology sector...
27 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
A New Drug Application has been made to the US Food and Drug Administration for the drug darolutamide to treat non-metastatic prostate cancer...
26 February 2019 | By European Pharmaceutical Review
The global antibiotics market is set to increase at a CAGR of 4 percent to $62.06 billion, due to the rising prevalence of infectious diseases...
21 February 2019 | By Hyglos-bioMerieux
This article covers the analytical criteria that apply to Bacterial Endotoxin Testing (BET) using Limulus Amebocyte Lysate (LAL) or recombinant Horseshoe crab Factor C (rFC) for the bioactivity determination of endotoxin in aqueous solutions, such as pharmaceuticals and medical device extracts. It explains the importance of these criteria for accurate…
21 February 2019 | By European Pharmaceutical Review
A study has shown that a 'smart drug' that delivers a toxic payload directly to tumour cells could be a possible treatment for breast cancer...
20 February 2019 | By European Pharmaceutical Review
A study has shown how structural barriers are one of the main reasons why clinical trials often do not meet their enrolment targets...
19 February 2019 | By European Pharmaceutical Review
A study has found that the FDA failed to design and implement an effective monitoring program for Transmucosal Immediate-Release Fentanyls...
19 February 2019 | By European Pharmaceutical Review
Researchers have found that fluconazole used to treat yeast infections in pregnant women could cause a higher risk of miscarriage...
18 February 2019 | By European Pharmaceutical Review
A UK based biotech firm has been awarded a grant to develop a treatment for osteoarthritis, after promising results from a Phase I trial...
15 February 2019 | By European Pharmaceutical Review
A Phase III clinical trial has shown that metastatic prostate cancer improved through the use of a combination therapy with enzalutamide...
15 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
Antiepileptic drugs have been found to have no association with dementia, with researchers looking at the data of over 50,000 patients...
Follow: